Related content

Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial

By Rastelli Antonella   Taylor Marie   Gao Feng   Armamento-Villareal Reina   Jamalabadi-Majidi Shohreh   Napoli Nicola   Ellis Matthew  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 107-116

Springer Publishing Company

Access to resources Recommend Favorite

Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes

By Dittmann K.   Virsik-köpp P.   Mayer C.   Rave-Fränk M.   Rodemann H. P.  

International Journal of Radiation Biology, Vol. 79, Iss. 10, 2003-10 ,pp. : 801-808

Informa Healthcare

Access to resources Recommend Favorite

Bowman-Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity

By Gueven N.   Dittmann K.   Mayer C.   Rodemann H. P.  

International Journal of Radiation Biology, Vol. 73, Iss. 2, 1998-02 ,pp. : 157-162

Informa Healthcare

Access to resources Recommend Favorite

Bowman-Birk protease inhibitor from soybeans enhances cisplatin-induced cytotoxicity in human mesothelioma cells

By              

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite